1.Epidemiological characteristics and trend of hospitalization of patients with herpes zoster in Beijing, 2017-2022
Lulu MENG ; Dan ZHAO ; Qinghai WANG ; Man ZHOU ; Tao WANG ; Zonglong ZHU ; Yaqiong WANG ; Ying FENG ; Xiaomei LI ; Ziang LI ; Jingbin PAN ; Luodan SUO ; Xinghuo PANG ; Li LU
Chinese Journal of Epidemiology 2025;46(9):1540-1545
Objective:To analyze the epidemiological characteristics and trend of hospitalization of the patients with herpes zoster in Beijing from 2017 to 2022.Methods:In this retrospective study, the information of hospitalization of herpes zoster patients were collected from all medical institutions at the first level and above in Xicheng, Changping, and Miyun districts of Beijing. The age and gender specific hospitalization rates and age-standardized hospitalization rates were calculated. Joinpoint regression model was used to explore the trend of the hospitalization rates, and the influencing factors of the hospital stay length and complications were analyzed.Results:The age-standardized hospitalization rate of the patients with herpes zoster was 10.82/100 000-18.43/100 000 in Beijing from 2017 to 2022 [annual percent change (APC) =5.86%, 95% CI: -2.80%-15.98%]. The age-standardized hospitalization rate of the cases with herpes zoster as the main diagnosis showed an upward trend (APC=11.35%, 95% CI: 7.21%-16.23%). The age-standardized hospitalization rate showed an upward trend in women (APC=14.34%, 95% CI: 7.95%-22.37%). The hospitalization rate showed a downward trend in age group 30-39 years (APC=-24.92%, 95% CI: -48.56% - -1.85%) and showed upward trends in age group 70-79 years and 80-109 years (APC=23.18%, 95% CI: 13.53%-35.58%; APC=4.90%, 95% CI: 1.18%-9.19%). Complications occurred in 66.28% (680/1 026) of the patients. The median hospital stay length was 9 (5,15) days, and the patients with high age (≥80 years) and two or more complications had longer hospital stay, which were 12 (6, 23) and 14 (7, 27) days respectively ( P<0.001). Conclusions:The hospitalization rate in women and the elderly aged ≥70 years with herpes zoster as the main diagnosis showed upward trends in Beijing in recent years. The elderly aged ≥80 years usually had longer hospital stay, showing a relatively disease burden level. More attention should be paid to development of intervention strategies, such as vaccine, for this population.
2.Incidence trend of herpes zoster and postherpetic neuralgia in Beijing City from 2015 to 2022
Xiaomei LI ; Ziang LI ; Dan ZHAO ; Luodan SUO ; Qinghai WANG ; Haihong WANG ; Xinghui PENG ; Jingbin PAN ; Tao ZHOU ; Xu WANG ; Man ZHOU ; Tao WANG ; Zonglong ZHU ; Huayong WANG ; Yanfei WANG ; Yaqiong WANG ; Ying FENG ; Li LU
Chinese Journal of Preventive Medicine 2025;59(8):1264-1269
Objective:To understand the incidence rate of herpes zoster (HZ) and postherpetic neuralgia (PHN) in Beijing, and analyze the incidence trend of HZ and PHN from 2015 to 2022.Methods:Cases of HZ and PHN from 2015 to 2022 were retrieved from the Hospital Information Systems (HIS) of all primary and above hospitals/clinics in three districts representing the urban, inner suburban, and outer suburban areas of Beijing. After duplication screening, the first visit cases were screened, and the incidence characteristics were described. The incidence rate of HZ and PHN in each year by sex and age group and the age-standardized incidence rate were calculated. The annual percentage increase (APC) of incidence rate was calculated using the Joint regression model, and the change trend was analyzed.Results:The age-standardized incidence rate of HZ in Beijing from 2015 to 2022 ranged from 7.44‰ to 10.05‰, with an average annual incidence rate of 8.95 ‰, significantly increasing with age ( P<0.001). The Joinpoint regression model showed that the overall age-standardized incidence of HZ remained relatively stable, with no significant difference (APC=2.28%, t=1.56, P=0.170). However, the incidence rate among the 0-19-year-old group exhibited a trend of decrease (APC=-10.70%, t=-6.29, P<0.001). For PHN, the age-standardized incidence in Beijing ranged from 0.77‰ to 2.67‰, with an average annual incidence rate of 1.59‰ and a proportion of 9.48% to 26.86% among HZ cases. Both the incidence of PHN and its proportion among HZ cases increased with age ( P<0.001). The age-standardized incidence of PHN increased annually (APC=18.56%, t=9.02, P<0.001). Conclusion:The incidence rate of HZ and PHN in Beijing continues to be at a high level, and PHN shows an increasing trend over time.
3.The effect of paeoniflorin on inflammatory response in rats with periapical periodontitis by regulating TLR4/MyD88/NF-κB signaling pathway
Hui SHEN ; Jing WANG ; Yapeng ZHAO ; Yaqiong CHEN
Immunological Journal 2025;41(1):24-28
Objective To explore the effect of paeoniflorin on the inflammatory response in rats with periapical periodontitis by regulating the TLR4/MyD88/NF-κB pathway.Methods Periapical periodontitis model was established in 72 rats,which were then randomly divided into 6 groups:model group,model+low-dose paeoniflorin(model+paeoniflorin-L,5 mg/kg)group,model+medium-dose paeoniflorin(model+paeoniflorin-M,10 mg/kg)group,model+high-dose paeoniflorin(model+paeoniflorin-H,20 mg/kg)group,and model+paeoniflorin-H+TLR4 activator(LPS)group(model+paeoniflorin-H+LPS,1 μg/kg LPS),with 12 rats in each group.In addition,12 normal rats were included as the control check(CK)group.The levels of CRP,IL-6 and IL-2 were detected by ELISA;the damage of periapical tissues was observed by HE staining;the number of tartrate-resistant acid phosphatase(TRAP)-positive osteoclasts was detected by TRAP staining;the level of cathepsin K and the proteins related to the TLR4/MyD88/NF-κB pathway were detected by Western blotting.Results There were very few inflammatory cells in the CK group,while there was a large accumulation of inflammatory cells in the model group.The expression levels of CRP,IL-6,IL-2,tissue protease K,osteoclast positive cells,TLR4,MyD88,p-NF-κB p65/NF-κB p65 proteins in the model group were higher than those in the CK group(P<0.05).Compared with the model group,the above-mentioned indicators in the model+paeoniflorin-L group,model+paeoniflorin-M group,and model+paeoniflorin-H group decreased successively(P<0.05).Compared with the model+paeoniflorin-H group,the above-mentioned indicators in the model+paeoniflorin-H+LPS group increased(P<0.05).Conclusion Paeoniflorin may alleviate the inflammatory response in rats with periapical periodontitis by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
4.Status and factors influencing postoperative kinesiophobia in patients with ankle fracture and its nursing countermeasures
Tingting HAN ; Mingyu CAO ; Jishuai LIU ; Yaqiong ZHAO
Modern Clinical Nursing 2025;24(9):27-33
Objective To investigate status of postoperative kinesiophobia in patients with ankle fracture and to identify the factors influencing kinesiophobia,thereby offering references for developing targeted nursing interventions.Methods A cross-sectional study was conducted between June 2023 and May 2024.With convenience sampling,338 first-time ankle fracture patients who received surgical treatment were recruited from a Tier-IIIA orthopaedic hospital in Xinjiang.Data was collected among the patients at 24 hours after surgery through the general information questionnaire,kinesiophobia scoring scale,pain visual analogue scale,hospital anxiety and depression scale,social support rating scale and general self-efficacy scale.Logistic regression was employed to identify factors influencing kinesiophobia.Results A total of 320 patients completed the study.The prevalence among the patients with kinesiophobia was 38.1%,and scored at(39.6±1.5).Logistic regression analysis identified that the pain,social support and self-efficacy were the independent risk factors of kinesiophobia(all P<0.05).Conclusion Patients with ankle fractures have a high prevalence of postoperative kinesiophobia.Pain,social support and self-efficacy are the key factors that influence kinesiophobia.Intervention strategies should be adopted in response to the influencing factors in order to promote the recovery of patients.
5.Epidemiological characteristics and trend of hospitalization of patients with herpes zoster in Beijing, 2017-2022
Lulu MENG ; Dan ZHAO ; Qinghai WANG ; Man ZHOU ; Tao WANG ; Zonglong ZHU ; Yaqiong WANG ; Ying FENG ; Xiaomei LI ; Ziang LI ; Jingbin PAN ; Luodan SUO ; Xinghuo PANG ; Li LU
Chinese Journal of Epidemiology 2025;46(9):1540-1545
Objective:To analyze the epidemiological characteristics and trend of hospitalization of the patients with herpes zoster in Beijing from 2017 to 2022.Methods:In this retrospective study, the information of hospitalization of herpes zoster patients were collected from all medical institutions at the first level and above in Xicheng, Changping, and Miyun districts of Beijing. The age and gender specific hospitalization rates and age-standardized hospitalization rates were calculated. Joinpoint regression model was used to explore the trend of the hospitalization rates, and the influencing factors of the hospital stay length and complications were analyzed.Results:The age-standardized hospitalization rate of the patients with herpes zoster was 10.82/100 000-18.43/100 000 in Beijing from 2017 to 2022 [annual percent change (APC) =5.86%, 95% CI: -2.80%-15.98%]. The age-standardized hospitalization rate of the cases with herpes zoster as the main diagnosis showed an upward trend (APC=11.35%, 95% CI: 7.21%-16.23%). The age-standardized hospitalization rate showed an upward trend in women (APC=14.34%, 95% CI: 7.95%-22.37%). The hospitalization rate showed a downward trend in age group 30-39 years (APC=-24.92%, 95% CI: -48.56% - -1.85%) and showed upward trends in age group 70-79 years and 80-109 years (APC=23.18%, 95% CI: 13.53%-35.58%; APC=4.90%, 95% CI: 1.18%-9.19%). Complications occurred in 66.28% (680/1 026) of the patients. The median hospital stay length was 9 (5,15) days, and the patients with high age (≥80 years) and two or more complications had longer hospital stay, which were 12 (6, 23) and 14 (7, 27) days respectively ( P<0.001). Conclusions:The hospitalization rate in women and the elderly aged ≥70 years with herpes zoster as the main diagnosis showed upward trends in Beijing in recent years. The elderly aged ≥80 years usually had longer hospital stay, showing a relatively disease burden level. More attention should be paid to development of intervention strategies, such as vaccine, for this population.
6.Status and factors influencing postoperative kinesiophobia in patients with ankle fracture and its nursing countermeasures
Tingting HAN ; Mingyu CAO ; Jishuai LIU ; Yaqiong ZHAO
Modern Clinical Nursing 2025;24(9):27-33
Objective To investigate status of postoperative kinesiophobia in patients with ankle fracture and to identify the factors influencing kinesiophobia,thereby offering references for developing targeted nursing interventions.Methods A cross-sectional study was conducted between June 2023 and May 2024.With convenience sampling,338 first-time ankle fracture patients who received surgical treatment were recruited from a Tier-IIIA orthopaedic hospital in Xinjiang.Data was collected among the patients at 24 hours after surgery through the general information questionnaire,kinesiophobia scoring scale,pain visual analogue scale,hospital anxiety and depression scale,social support rating scale and general self-efficacy scale.Logistic regression was employed to identify factors influencing kinesiophobia.Results A total of 320 patients completed the study.The prevalence among the patients with kinesiophobia was 38.1%,and scored at(39.6±1.5).Logistic regression analysis identified that the pain,social support and self-efficacy were the independent risk factors of kinesiophobia(all P<0.05).Conclusion Patients with ankle fractures have a high prevalence of postoperative kinesiophobia.Pain,social support and self-efficacy are the key factors that influence kinesiophobia.Intervention strategies should be adopted in response to the influencing factors in order to promote the recovery of patients.
7.Incidence trend of herpes zoster and postherpetic neuralgia in Beijing City from 2015 to 2022
Xiaomei LI ; Ziang LI ; Dan ZHAO ; Luodan SUO ; Qinghai WANG ; Haihong WANG ; Xinghui PENG ; Jingbin PAN ; Tao ZHOU ; Xu WANG ; Man ZHOU ; Tao WANG ; Zonglong ZHU ; Huayong WANG ; Yanfei WANG ; Yaqiong WANG ; Ying FENG ; Li LU
Chinese Journal of Preventive Medicine 2025;59(8):1264-1269
Objective:To understand the incidence rate of herpes zoster (HZ) and postherpetic neuralgia (PHN) in Beijing, and analyze the incidence trend of HZ and PHN from 2015 to 2022.Methods:Cases of HZ and PHN from 2015 to 2022 were retrieved from the Hospital Information Systems (HIS) of all primary and above hospitals/clinics in three districts representing the urban, inner suburban, and outer suburban areas of Beijing. After duplication screening, the first visit cases were screened, and the incidence characteristics were described. The incidence rate of HZ and PHN in each year by sex and age group and the age-standardized incidence rate were calculated. The annual percentage increase (APC) of incidence rate was calculated using the Joint regression model, and the change trend was analyzed.Results:The age-standardized incidence rate of HZ in Beijing from 2015 to 2022 ranged from 7.44‰ to 10.05‰, with an average annual incidence rate of 8.95 ‰, significantly increasing with age ( P<0.001). The Joinpoint regression model showed that the overall age-standardized incidence of HZ remained relatively stable, with no significant difference (APC=2.28%, t=1.56, P=0.170). However, the incidence rate among the 0-19-year-old group exhibited a trend of decrease (APC=-10.70%, t=-6.29, P<0.001). For PHN, the age-standardized incidence in Beijing ranged from 0.77‰ to 2.67‰, with an average annual incidence rate of 1.59‰ and a proportion of 9.48% to 26.86% among HZ cases. Both the incidence of PHN and its proportion among HZ cases increased with age ( P<0.001). The age-standardized incidence of PHN increased annually (APC=18.56%, t=9.02, P<0.001). Conclusion:The incidence rate of HZ and PHN in Beijing continues to be at a high level, and PHN shows an increasing trend over time.
8.The effect of paeoniflorin on inflammatory response in rats with periapical periodontitis by regulating TLR4/MyD88/NF-κB signaling pathway
Hui SHEN ; Jing WANG ; Yapeng ZHAO ; Yaqiong CHEN
Immunological Journal 2025;41(1):24-28
Objective To explore the effect of paeoniflorin on the inflammatory response in rats with periapical periodontitis by regulating the TLR4/MyD88/NF-κB pathway.Methods Periapical periodontitis model was established in 72 rats,which were then randomly divided into 6 groups:model group,model+low-dose paeoniflorin(model+paeoniflorin-L,5 mg/kg)group,model+medium-dose paeoniflorin(model+paeoniflorin-M,10 mg/kg)group,model+high-dose paeoniflorin(model+paeoniflorin-H,20 mg/kg)group,and model+paeoniflorin-H+TLR4 activator(LPS)group(model+paeoniflorin-H+LPS,1 μg/kg LPS),with 12 rats in each group.In addition,12 normal rats were included as the control check(CK)group.The levels of CRP,IL-6 and IL-2 were detected by ELISA;the damage of periapical tissues was observed by HE staining;the number of tartrate-resistant acid phosphatase(TRAP)-positive osteoclasts was detected by TRAP staining;the level of cathepsin K and the proteins related to the TLR4/MyD88/NF-κB pathway were detected by Western blotting.Results There were very few inflammatory cells in the CK group,while there was a large accumulation of inflammatory cells in the model group.The expression levels of CRP,IL-6,IL-2,tissue protease K,osteoclast positive cells,TLR4,MyD88,p-NF-κB p65/NF-κB p65 proteins in the model group were higher than those in the CK group(P<0.05).Compared with the model group,the above-mentioned indicators in the model+paeoniflorin-L group,model+paeoniflorin-M group,and model+paeoniflorin-H group decreased successively(P<0.05).Compared with the model+paeoniflorin-H group,the above-mentioned indicators in the model+paeoniflorin-H+LPS group increased(P<0.05).Conclusion Paeoniflorin may alleviate the inflammatory response in rats with periapical periodontitis by inhibiting the TLR4/MyD88/NF-κB signaling pathway.
9.Role of podoplanin in hepatic stellate cell activation and liver fibrosis
Zhiyi WANG ; Guangyue YANG ; Wei ZHANG ; Yaqiong PU ; Xin ZHAO ; Wenting MA ; Xuling LIU ; Liu WU ; Le TAO ; Cheng LIU
Journal of Clinical Hepatology 2024;40(3):533-538
ObjectiveTo investigate the role and mechanism of podoplanin (PDPN) in hepatic stellate cell (HSC) activation and liver fibrosis. MethodsLiver biopsy samples were collected from 75 patients with chronic hepatitis B who attended Department of Infectious Diseases, Putuo Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, for the first time from September 2019 to June 2022, and RT-PCR and immunohistochemistry were used to measure the expression of PDPN in liver tissue of patients in different stages of liver fibrosis. A total of 12 male C57/BL6 mice were randomly divided into control group and model group. The mice in the model group were given intraperitoneal injection of 10% CCl4, and those in the control group were injected with an equal volume of olive oil, for 6 weeks. HE staining and Sirius Red staining were used to observe liver histopathological changes; primary mouse liver cells were separated to measure the mRNA expression of PDPN in various types of cells; primary mouse HSCs were treated with PDPN protein, followed by treatment with the NF-κB inhibitor BAY11-708, to measure the expression of inflammatory factors in HSCs induced by PDPN. The independent-samples t test was used for comparison of normally distributed continuous data between two groups; a one-way analysis of variance was used for comparison between multiple groups, and the least significant difference t-test was used for further comparison between two groups. The Spearman correlation analysis was used to investigate data correlation. ResultsAs for the liver biopsy samples, there was a relatively low mRNA expression level of PDPN in normal liver, and there was a significant increase in the mRNA expression level of PDPN in liver tissue of stage S3 or S4 fibrosis (all P<0.001). Immunohistochemical staining showed that PDPN was mainly expressed in the fibrous septum and the hepatic sinusoid, and the PDPN-positive area in S4 liver tissue was significantly higher than that in S0 liver tissue (t=8.892, P=0.001). In normal mice, PDPN was mainly expressed in the hepatic sinusoid, and there was a significant increase in the expression of PDPN in CCl4 model mice (t=0.95, P<0.001), mainly in the fibrous septum. RT-PCR showed a significant increase in the mRNA expression of PDPN in the CCl4 model mice (t=11.25, P=0.002). Compared with hepatocytes, HSCs, Kupffer cells, and bile duct endothelial cells, hepatic sinusoidal endothelial cells showed a significantly high expression level of PDPN (F=20.56, P<0.001). Compared with the control group, the primary mouse HSCs treated by PDPN protein for 15 minutes showed significant increases in the mRNA expression levels of the inflammation-related factors TNFα, CCL3, CXCL1, and CXCR1 (all P<0.05), and there were significant reductions in the levels of these indicators after treatment with BAY11-7082 (all P<0.05). ConclusionThere is an increase in the expression of PDPN mainly in hepatic sinusoidal endothelial cells during liver fibrosis, and PDPN regulates HSC activation and promotes the progression of liver fibrosis via the NF-κB signaling pathway.
10.Study of coverage of influenza and pneumonia vaccinations in children and influencing factors in two areas, China
Xianming CAI ; Wu LIU ; Chunyan ZHAO ; Linyi CHEN ; Tianshuo ZHAO ; Hanyu LIU ; Jing ZENG ; Ninghua HUANG ; Yaqiong LIU ; Qingbin LU ; Fuqiang CUI
Chinese Journal of Epidemiology 2023;44(11):1731-1737
Objective:To explore the coverage of influenza and pneumonia vaccination and factors influencing the vaccination in children.Methods:A cross-sectional questionnaire survey was conducted in children's parents in Beijing and Gansu by using two-stage cluster-sampling to investigate the influenza and pneumonia vaccination rates and influencing factors in children.Results:A total of 2 377 parents were included in the study, and the results indicated that the influenza vaccination coverage was 35.93% and the pneumonia vaccination coverage was 16.58% in children in survey areas, the vaccination rate of both vaccines was 11.65%. The top three reasons for vaccination for both vaccines were being aware of severity of the diseases (influenza vaccine: 36.02%; pneumonia vaccine: 49.61%), being required by school or organization (influenza vaccine: 28.76%; pneumonia vaccine: 25.45%) and being aware of the susceptibility of the diseases (influenza vaccine: 26.41%; pneumonia vaccine: 13.88%). The top three reasons for having no vaccinations were personal unwillingness, concern about vaccine and vaccine accessibility. Families with multi children, living in rural areas and lower family income were the negative factors for both types of vaccinations.Conclusions:The influenza and pneumonia vaccination coverage in children need further improvement, and rural families and families with multi children are the key concern groups for expanding vaccination coverage. Health education about influenza and pneumonia vaccinations, coordinating vaccine supply and decreasing vaccine prices play an important role in improving influenza and pneumonia vaccination coverage.

Result Analysis
Print
Save
E-mail